RECOMMENDED IMMUNIZATIONS

Transcription

1 Recommended Immunization Schedule for Persons Aged 0 Through 6 Years United States Vaccine Age Birth month months months months months months months months years years Hepatitis B 1 HepB HepB HepB Rotavirus 2 RV RV RV 2 see Diphtheria, Tetanus, Pertussis 3 DTaP DTaP DTaP footnote 3 DTaP DTaP Haemophilus influenzae type b 4 Hib Hib Hib 4 Hib Pneumococcal 5 PCV PCV PCV PCV PPSV ages for all children except certain high-risk groups Inactivated Poliovirus 6 IPV IPV IPV IPV Influenza 7 Influenza (Yearly) Measles, Mumps, Rubella 8 MMR see footnote 8 MMR Varicella 9 Varicella see footnote 9 Varicella ages for certain high-risk groups HepatitisA 10 HepA (2 doses) HepA Series Meningococcal 11 MCV This schedule includes recommendations in effect as of December 15, Any dose not administered Committee on Immunization Practices statement for detailed recommendations: at the age should be administered at a subsequent visit, when indicated and feasible. The vaccines/pubs/acip-list.htm. Clinically significant adverse events that follow immunization should be use of a combination vaccine generally is preferred over separate injections of its equivalent component reported to the Vaccine Adverse Event Reporting System (VAERS) at or by vaccines. Considerations should include provider assessment, patient preference, and the potential for telephone, adverse events. Providers should consult the relevant Advisory All footnotes are availabe at schedule.htm. The Recommended Immunization Schedules for Persons Aged 0 through 18 Years are approved by the Advisory Committee on Immunization Practices ( the American Academy of Pediatrics ( and the American Academy of Family Physicians ( Department of Health and Human Services Centers for Disease Control and Prevention

2 Recommended Immunization Schedule for Persons Aged 7 Through 18 Years United States 2010 Vaccine Age 7 10 years years years Tetanus, Diphtheria, Pertussis 1 Tdap Tdap Human Papillomavirus 2 see footnote 2 HPV (3 doses) HPV series Meningococcal 3 MCV MCV MCV Influenza 4 Influenza (Yearly) Pneumococcal 5 PPSV Hepatitis A 6 HepA Series Hepatitis B 7 HepB Series Inactivated Poliovirus 8 IPV Series Measles, Mumps, Rubella 9 MMR Series Varicella 10 Varicella Series ages for all children except certain high-risk groups ages for catch-up immunization ages for certain high-risk groups This schedule includes recommendations in effect as for adverse events. Providers should consult the of December 15, Any dose not administered relevant Advisory Committee on Immunization at the age should be administered at Practices statement for detailed recommendations: a subsequent visit, when indicated and feasible. The use of a combination vaccine generally is preferred Clinically significant adverse events that follow over separate injections of its equivalent component immunization should be reported to the Vaccine vaccines. Considerations should include provider Adverse Event Reporting System (VAERS) at assessment, patient preference, and the potential or by telephone, All footnotes are available at The Recommended Immunization Schedules for Persons Aged 0 through 18 Years are approved by the Advisory Committee on Immunization Practices ( the American Academy of Pediatrics ( and the American Academy of Family Physicians ( Department of Health and Human Services Centers for Disease Control and Prevention

3 Recommended Adult Immunization Schedule UNITED STATES 2010 VACCINE AGE GROUP years years years years 65 years Tetanus, diphtheria, pertussis Td booster Substitute 1-time dose of Tdap for Td booster; then boost with Td every 10 yrs (Td/Tdap) 1,* every 10 yrs Human papillomavirus(hpv) 2,* 3 doses (females) Varicella 3,* 2 doses Zoster 4 1 dose Measles, mumps, rubella (MMR) 5,* 1 or 2 doses 1 dose Influenza 6,* 1dose annually Pneumococcal (polysaccharide) 7,8 1 or 2 doses 1 dose Hepatitis A 9,* 2 doses Hepatitis B 10,* 3 doses Meningococcal 11,* 1 or more doses *Covered by the Vaccine Injury Compensation Program. For all persons in this category who meet the age Recommended if some other risk factor is present No recommendation requirements and who lack evidence of immunity (e.g., on the basis of medical, occupational, lifestyle, (e.g., lack documentation of vaccination or have no or other indications) evidence of prior infection)

4 Vaccines that might be indicated for adults based on medical and other indications United States 2010 VACCINE Asplenia 12 Immuno- HIV Diabetes, (including compromising infection 3 5,12,13 heart disease, elective Kidney failure, end-stage renal conditions CD4 T lympho- chronic splenectomy Chronic liver Health-care INDICATION Pregnancy cyte count disease, (excluding human lung disease, and persistent disease personnel receipt of immunodeficiency chronic complement hemodialysis virus [HIV]) 3 5,13 cells/ L cells/ L alcoholism component deficiencies) Tetanus, diphtheria, pertussis (Td/Tdap) 1,* Td Substitute 1-time dose of Tdap for Td booster; then boost with Td every 10 yrs Human papillomavirus (HPV) 2,* 3 doses for females through age 26 yrs Varicella 3,* Contraindicated 2 doses Zoster 4 Contraindicated 1 dose Measles, mumps, rubella (MMR) 5,* Contraindicated 1 or 2 doses 1 dose TIV Influenza 6,* 1 dose TIV annually or LAIV annually Pneumococcal (polysaccharide) 7,8 1 or 2 doses (Continued)

5 VACCINE Asplenia 12 Immuno- HIV Diabetes, (including compromising infection 3 5,12,13 heart disease, elective Kidney failure, end-stage renal conditions CD4 T lympho- chronic splenectomy Chronic liver Health-care INDICATION Pregnancy cyte count disease, (excluding human lung disease, and persistent disease personnel receipt of immunodeficiency chronic complement hemodialysis virus [HIV]) 3 5,13 cells/ L cells/ L alcoholism component deficiencies) Hepatitis A 9,* 2 doses Hepatitis B 10,* 3 doses Meningococcal 11,* 1ormoredoses *Covered by the Vaccine Injury Compensation Program. For all persons in this category who meet the age Recommended if some other risk factor is present No recommendation requirements and who lack evidence of immunity (e.g., on the basis of medical, occupational, lifestyle, (e.g., lack documentation of vaccination or have or other indications) no evidence of prior infection) These schedules indicate the age groups and medical indications for which administration of currently licensed vaccines is commonly indicated for adults ages 19 years and older, as of January 1, Licensed combination vaccines may be used whenever any components of the combination are indicated and when the vaccine s other components are not contraindicated. For detailed recommendations on all vaccines, including those used primarily for travelers or that are issued during the year, consult the manufacturers package inserts and the complete statements from the Advisory Committee on Immunization Practices ( vaccines/pubs/acip-list.htm). The recommendations in this schedule were approved by the Centers for Disease Control and Prevention s (CDC) Advisory Committee on Immunization Practices (ACIP), the American Academy of Family Physicians (AAFP), the American College of Obstetricians and Gynecologists (ACOG), and the American College of Physicians (ACP).